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ABSTRACT
Introduction Knee replacements are highly successful 
for many people, but if a knee replacement fails, revision 
surgery is generally required. Surgeons and patients 
may choose from a range of implant components and 
combinations that make up knee replacement constructs, 
all with potential implications for how long a knee 
replacement will last. To inform surgeon and patient 
decisions, a comprehensive synthesis of data from 
randomised controlled trials is needed to evaluate the 
effects of different knee replacement implants on overall 
construct survival. Due to limited follow- up in trials, joint 
registry analyses are also needed to assess the long- term 
survival of constructs. Finally, economic modelling can 
identify cost- effective knee replacement constructs for 
different patient groups.
Methods and analysis In this protocol, we describe 
systematic reviews and network meta- analyses 
to synthesise evidence on the effectiveness of 
knee replacement constructs used in total and 
unicompartmental knee replacement and analyses of two 
national joint registries to assess long- term outcomes. 
Knee replacement constructs are defined by bearing 
materials and mobility, constraint, fixation and patella 
resurfacing. For men and women in different age groups, 
we will compare the lifetime cost- effectiveness of knee 
replacement constructs.
Ethics and dissemination Systematic reviews are 
secondary analyses of published data with no ethical 
approval required. We will design a common joint registry 
analysis plan and provide registry representatives 
with information for submission to research or ethics 
committees. The project has been assessed by the 
National Health Service (NHS) REC committee and does not 
require ethical review.
Strengths and limitations of this study
 ► Bringing evidence from multiple randomised con-
trolled trials (RCTs) together in systematic reviews 
and meta- analysis with thorough assessments of 
risk of bias and confidence in the evidence ensures 
that health professionals have the information they 
need to deliver a high- quality patient experience 
with safe, clinically effective and cost- effective 
treatments.
 ► If there are insufficient data to build the economic model 
using the network of RCT studies in the literature, we will 
base our economic model on analyses of registry data. 
The joint registries that we will analyse include large num-
bers of patients with information on knee replacement 
constructs used and patient demographics such as age 
and sex to enable adjustment for potential confounders.
 ► A limitation of the systematic review elements of our 
project is the likely inclusion of small RCTs with short 
follow- up; many RCTs of knee replacement constructs 
report radiographic outcomes, which do not necessar-
ily require large sample sizes and long- term follow- up. 
Some studies we identify may not report relevant out-
comes or be at high risk of bias that will reduce the 
number of studies and knee replacement constructs 
that we can include in analyses.
 ► A limitation of our registry analyses is that treatment 
choices are made for individual patients, and uncon-
trolled confounding factors may influence outcomes.
 ► Exploring the effectiveness of knee replacement con-
structs in both RCTs and registries, and linking this in-
formation to implant and healthcare costs, will allow us 
to compare the lifetime cost- effectiveness of different 
knee replacement constructs.
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Study findings will be disseminated to clinicians, researchers and 
administrators through open access articles, presentations and websites. 
Specific UK- based groups will be informed of results including National 
Institute for Health Research and National Institute for Health and Care 
Excellence, as well as international orthopaedic associations and charities. 
Effective dissemination to patients will be guided by our patient–public 
involvement group and include written lay summaries and infographics.
PROSPERO registration number CRD42019134059 and 
CRD42019138015.
INTRODUCTION
In 2018, more than 100 000 primary knee replacements 
were performed in the UK1 2 and over 15 400 in Sweden, 
our collaborating country.3 About 96% of operations are to 
treat end- stage osteoarthritis, with the majority in women 
(57%) at a mean age of 69 years.1 For many people, knee 
replacements are highly successful and can last a person’s 
lifetime.4 However, when a knee replacement fails, most 
commonly due to loosening or wear, people may require 
revision surgery. Revision surgery is more complex for 
clinicians to perform, is difficult for patients to recover 
from, is associated with further complications and need 
for rerevisions and is costly.
Description of the intervention
The knee joint consists of three compartments: the 
medial femorotibial, the lateral femorotibial and the 
patellofemoral, all of which can be affected by osteoar-
thritis with associated pain and disability. Depending on 
which compartments are affected, a surgeon may perform 
a total knee replacement (TKR) or a unicompartmental 
knee replacement (UKR). In TKR, both the medial and 
lateral compartments are replaced as well as the trochlea 
(groove) on the front of the femur. The patella that artic-
ulates with this may be resurfaced or not. Some surgeons 
favour UKR on the basis of radiographic evidence of 
osteoarthritis affecting a single medial or lateral compart-
ment with estimates of patient eligibility for UKR as 
high as 48% of all people receiving knee replacement,5 
although actual rates of utilisation are around 10%.1 3 
Compared with TKR, UKR surgery requires a less invasive 
procedure, retains more bone and native ligaments, the 
operation has a shorter duration, is quicker for patients to 
recover from and is cheaper for the NHS. However, with 
time, osteoarthritis can develop in the other compart-
ments, and a patient with a UKR is more than twice as 
likely to undergo revision than a patient who has had a 
TKR.1 Revision of UKR to TKR can be complex and may 
include treatment of bone defects.6 Thus, many surgeons 
favour TKR as the first treatment for severe knee osteoar-
thritis. In the National Joint Registry for England, Wales, 
Northern Ireland and the Isle of Man (NJR), 87.4% of 
knee replacements performed in 2018 were TKR and 
11% UKR.1 In 2018, in the Swedish Knee Arthroplasty 
Register (SKAR), 90.0% of knee replacements were TKR 
and 9.6% UKR.3
In both TKR and UKR, the remaining cartilage and 
some bone in the affected portion of the joint is removed 
and replaced, typically with implants made of metal fixed 
to the bone and polyethylene bearing surfaces between 
the metal implants or affixed directly to the bone. Stability 
of the knee relies to a large degree on the ligaments in 
and around the knee. In UKR, these are retained; in TKR, 
some of them are removed and their function compen-
sated for by the implants used.
TKR construct options
Surgeons and patients may choose from a range of 
implant components and combinations that make up 
knee replacement constructs, all with potential implica-
tions for how long a knee replacement will last.
In a modular TKR construct, the polyethylene liner 
between the metal femoral and tibial components can 
be ‘fixed’ to the tibial component or ‘mobile’ with move-
ment of the liner permitted on the tibial component. In a 
‘monobloc’ implant, the top of the tibia is replaced with 
a one- piece polyethylene or metal backed implant that is 
fixed directly to the bone.
TKR constructs can accommodate keeping the poste-
rior cruciate ligament (cruciate retaining) or not 
(cruciate sacrificing or posterior stabilised). Depending 
on the condition of the patella and the opinion of the 
surgeon, the patella can be resurfaced with a polyeth-
ylene or metal- backed polyethylene implant.
Fixation of both femoral and tibial components to 
their respective bones is done with or without the use of 
cement. Alternatively, in a hybrid TKR, the tibial compo-
nent is fixed with cement while the femoral component 
is uncemented. More recently, inverse (or reverse) hybrid 
fixation with uncemented tibial and cemented femoral 
components has been reported as a distinct combina-
tion.7 Patella resurfacing can be with a cemented or 
cementless design(table 1).
UKR construct options
Depending on which compartment is affected and 
replaced, UKRs can be medial UKR, lateral UKR or 
patellofemoral UKR. As with TKR, component options 
are available to surgeons performing a UKR. The polyeth-
ylene liner may be fixed or mobile, and implants can be 
fixed to bone with cement, without cement (uncemented) 
or using a combination (hybrid). In patellofemoral UKR, 
the back of the patella and trochlea of the femur are 
resurfaced with polyethylene and metal, respectively. In 
rare situations, surgeons may perform multiple UKRs of 
different compartments at the same time8 (table 1).
Effectiveness and cost-effectiveness of knee replacement 
constructs: existing knowledge
To assess the relevance of our proposed research, we 
performed a scoping literature search of MEDLINE and 
Embase in January 2020 to identify existing network 
meta- analyses relating to knee replacement. Most of the 
33 studies we identified considered drug treatments. 
Two systematic reviews and one protocol described the 
application of network meta- analysis to knee replacement 
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constructs. One study compared resurfacing of the 
patella with no resurfacing and, to complete the network, 
with patella denervation.9 While the authors concluded 
that patella resurfacing was associated with a lower rate of 
reoperation than not resurfacing the patella and with no 
benefit for pain or surgeon- assessed scores, there was no 
attempt to interpret results in the context of assessed risk 
of bias of included studies. Another systematic review of 
different surgeries for the treatment of osteoarthritis with 
network meta- analysis only included cohort studies and 
did not assess their risk of bias.10 A third Cochrane review 
protocol describing a network meta- analysis to compare 
diverse surgical and medical therapies in TKR11 was with-
drawn in September 2019.12
In a second contemporaneous search of MEDLINE 
and Embase for systematic reviews, we identified six that 
explicitly considered the cost- effectiveness of different 
knee replacement constructs. The potential value of 
patella resurfacing was evaluated in one systematic 
review.13 Over 5 years, the authors concluded that there 
was a small cost- saving when the patella was resurfaced. 
However, there was no consideration of risk of bias. In 
one systematic review, the authors concluded that the 
benefit of UKR compared with TKR is dependent on 
the economic perspective chosen, patient characteristics 
and the timing of outcome.14 In three reviews, authors 
concluded that UKR may be a cost- effective outcome in 
older patients but that this was uncertain for younger 
patients due to lower survivorship associated with UKR 
constructs.15–17 In another systematic review comparing 
UKR, TKR and other procedures, results presented narra-
tively were equivocal.18
A further search for economic analyses and registry 
studies identified 13 potentially relevant studies. Registry 
analyses covered bearing surfaces,19–21 monobloc tibial 
components,22 patella resurfacing,23 mobile and high 
flexion designs,20 fixation,24 patellofemoral replace-
ment25 and UKR.17 26–28 We did not find any registry 
studies comparable with our study comparing diverse 
features of knee replacement constructs. The authors 
of one study presented a cost- effectiveness model based 
on five common brands of TKR implants up to 10- year 
postprimary surgery.29 Each brand studied represented 
a construct with cemented unconstrained components 
with fixed bearings, in contrast with our approach, which 
focuses on different constructs.
A search of PROSPERO in January 2020 identified no 
network meta- analyses in knee replacement comparing 
knee replacement constructs comparable with our 
planned study.
Objectives
The objectives of our study are to synthesise evidence 
from randomised controlled trials (RCTs), registries and 
studies reporting quality of life and cost information to 
identify:
1. The most effective and cost- effective TKR constructs 
for patients of different age and sex profiles.
2. The most effective and cost- effective knee replacement 
constructs for patients of different age and sex profiles 
eligible for both TKR and UKR.
We will achieve these objectives by conducting two 
systematic reviews to identify RCT evidence for each ques-
tion, analysis of registries from the UK and Sweden to 
estimate long- term revision and mortality rates, and devel-
opment of a cost- effectiveness model for each question.
The primary outcome in both systematic reviews will be 
revision rate and timing of revision that are key markers 
Table 1 Knee construct options
Total knee replacement
Bearing mobility Fixed bearing. Mobile bearing.





Fixation Cemented. Uncemented. Hybrid. Inverse hybrid.
Bearing materials Metal bearing on 
conventional or 
highly cross- linked 
polyethylene tray.
Metal femoral 
component on all- 
















Unicompartmental knee replacement (medial or lateral)
Bearing mobility Fixed bearings. Mobile bearing.
Constraint Cruciate retaining.
Fixation Cemented. Uncemented. Hybrid.
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of construct effectiveness. Secondary outcomes will be 
patient- reported pain and function, and surgeon- assessed 
outcomes.
As the implants that make up a construct can vary in TKR 
and UKR, network meta- analysis with direct and indirect 
comparisons is an appropriate method for synthesis of 
data from RCTs. We will develop networks of evidence for 
revision (and other outcomes) at different time periods 
after primary TKR and UKR. These will include an initial 
period postprimary surgery where the risk of first revision 
is high, a medium- term period with a lower risk of first 
revision and a late revision period, where risk of first revi-
sion increases.
Recognising the short follow- up in many orthopaedic 
RCTs, we will also analyse data on outcomes after different 
knee replacement constructs from two joint registries.
Outcome data from RCTs and registries, together with 
evidence on quality of life and construct and health 
service costs, will be used to inform economic decision 
models that will rank and estimate the cost- effectiveness 




The project will collect data and perform analyses 
between January 2019 and December 2021.
Patient and public involvement
This proposal was developed in collaboration with the 
University of Bristol Musculoskeletal Research Unit 
patient and public involvement group. The ‘Patient Expe-
rience Partnership in Research’ (PEP- R) group comprises 
nine members, most of whom have had joint replacement. 
Meetings are facilitated by a dedicated coordinator who 
works in partnership with researchers to provide patient 
and public input into research. We met with PEP- R on two 
occasions for input into the development of the research 
proposal in 2017 and 2018 and at the start of the project 
in 2019. Patients told us that they were not informed 
about knee implant options when discussing their surgery 
with the consultant. PEP- R will provide ongoing support 
throughout the study and appropriate funding is in place. 
Anticipated contributions will include advice on dissem-
ination of results, particularly plain language summaries 
and the use of our findings to support shared decision 
making.30
Systematic reviews and meta-analyses
The systematic reviews are registered with PROSPERO 
(CRD42019134059 and CRD42019138015), and a 
Preferred Reporting Items for Systematic Review and 
Meta- Analysis Protocols statement31 is provided. The 
research questions are formulated according to popu-
lation, intervention, control, and outcomes (PICO),32 
and review conduct will be based on methods described 
in the Cochrane Handbook for Systematic Reviews of 
Interventions.33 Reporting will adhere to the Preferred 
Reporting Items for Systematic Reviews and Meta- Analyses 
(PRISMA) guidelines34 and the PRISMA extension state-
ment for reporting of systematic reviews incorporating 
network meta- analyses.35
Systematic review 1: TKR
Eligibility criteria
Types of studies
We will include RCTs.
Participants
Eligible patients will be receiving elective primary TKR 
(unilateral or bilateral) and aged 18 years or older. There 
will be a diagnosis of osteoarthritis in 50% or more of the 
study population.
Interventions and comparators
We will include comparisons of knee replacement 
constructs as summarised in table 1. Each construct and 
comparator will have a combination defined by bearing 
mobility, constraint, fixation, bearing materials and 
patella resurfacing. In theory, this could be 240 different 
combinations, but many combinations are not feasible or 
desirable.
The reference construct within the network meta- 
analysis will be the most widely used TKR construct 
that has cemented, cruciate- retaining, fixed- bearing 
implant components with metal on polyethylene bearing 
materials.
Types of outcome measures
The primary outcome of the systematic reviews will be 
first revision surgery after primary TKR at any time from 
primary surgery. We will collect data at each time point 
reported in articles and, for revision outcome, extract 
data from published Kaplan- Meier plots if available.36
Secondary outcomes will include: further revision 
surgeries; deaths; reason for revision; patient- reported 
outcomes such as the Oxford Knee Score37 and Western 
Ontario and McMaster Universities Arthritis Index38; 
clinician- assessed measures including the American Knee 
Society Score (KSS)39 and Hospital for Special Surgery 
score40; and quality of life indices such as the EuroQol 
questionnaire.41
We will collect information on surgical complications 
and major adverse events including infection and deep 
vein thrombosis and on hospital readmissions.
Search strategy
Online databases to be searched from inception are 
MEDLINE, Embase and PsycINFO on Ovid, CINAHL 
on EBSCOhost and the Cochrane Library. Searches of 
PsycINFO and CINAHL are unlikely to identify further 
RCTs but are routinely searched in our department. 
Online databases will be searched so that searches are up 
to date in October 2020. The search strategy for appli-
cation in MEDLINE shown in box 1 will be tailored to 
each database. As well as RCTs, our searches will identify 
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systematic reviews that will be screened for RCTs as will 
reference lists of relevant RCTs. Citations of key articles 
will be tracked in Web of Science. We will identify clinical 
trial records in the Cochrane Library and check them for 
full publication. Should no further publication be iden-
tified, we will contact authors for details of progress and 
study results.
No language restrictions will be applied to searches or 
study inclusion. Translations will be made by colleagues 
or professional translators when required. Studies that 
are unobtainable through our library (including interli-
brary loans) and via author contact will be excluded. If 
studies have not reported any follow- up data or reporting 
is limited regarding outcomes and study conduct, 
including conference abstracts, we will contact authors 
for appropriate data. If not available, these studies will 




Records will be imported into Endnote X9 (Clarivate 
Analytics). An initial screen by one reviewer will exclude 
clearly irrelevant articles. Subsequently, abstracts and 
full articles will be screened independently in Covidence 
by two reviewers and reasons for exclusion recorded. 
Discrepancies between reviewers will be resolved by 
consensus with involvement of an orthopaedic surgeon 
or methodologist. Authors will be contacted by email to 
confirm eligibility if necessary. Multiple reports of RCTs 
will be grouped together as a single study defined by a 
key publication with follow- up data. Notices of errata and 
retractions will be sought.
Data extraction
After piloting of forms, data will be extracted into Covi-
dence, Microsoft Access or Excel by one reviewer. Data 
to be extracted will be: country; dates of recruitment; 
participant characteristics including indication, age 
and sex; inclusion and exclusion criteria; knee replace-
ment constructs defined by bearing mobility, constraint, 
fixation, bearing materials and patella resurfacing; 
other surgical methods including approach, alignment, 
Box 1 Continued
word, protocol supplementary concept) word, rare disease supple-
mentary concept) word, unique identifier, synonyms]
26. (knee$ adj3 endoprosthe$).mp. [mp=title, abstract, original title, 
name of substance word, subject heading word, floating sub- 
heading word, keyword heading word, organism supplementary 
concept) word, protocol supplementary concept) word, rare dis-






Box 1 Search strategy as applied in MEDLINE
1. Controlled clinical trial.pt.
2. Randomized controlled trial.pt.
3. Clinical trials as topic/
4. (randomi#ed or randomi#ation or randomi#ing).ti,ab,kf.
5. (rct or “at random” or (random* adj3 (administ* or allocat* or as-
sign* or class* or cluster or crossover or cross- over or control* or 
determine* or divide* or division or distribut* or expose* or fashion 




8. (control* adj3 group*).ab.
9. (control* and (trial or study or group*) and (waitlist* or wait* list* or 
((treatment or care) adj2 usual))).ti,ab,kf.
10. ((single or double or triple or treble) adj2 (blind* or mask* or dum-
my)).ti,ab,kf.
11. Double- blind method/ or random allocation/ or single- blind method/
12. Or/1–11
13. (systematic or structured or evidence or trials or studies).ti. And 
((review or overview or look or examination or update* or summa-
ry).ti. Or review.pt.)
14. 0266-4623(0266-4623 or 1469–493 x or 1366–5278 or 1530–
440 x or 2046–4053).is.
15. Meta- analysis.pt. Or (meta- analys* or meta analys* or metaanalys* 
or meta synth* or meta- synth* or metasynth*).ti,ab,kf,hw.
16. ((systematic or meta) adj2 (analys* or review)).ti,kf. Or ((systemat-
ic* or quantitativ* or methodologic*) adj5 (review* or overview*)).
ti,ab,kf,sh. Or (quantitativ$ adj5 synthesis$).ti,ab,kf,hw.
17. (integrative research review* or research integration).tw. Or scop-
ing review?.ti,kf. Or (review.ti,kf,pt. And (trials as topic or studies as 
topic).hw.) Or (evidence adj3 review*).ti,ab,kf.
18. Review.pt. And ((medline or medlars or embase or pubmed or sci-
search or psychinfo or psycinfo or psychlit or psyclit or cinahl or 
electronic database* or bibliographic database* or computeri#ed 
database* or online database* or pooling or pooled or mantel 
haenszel or peto or dersimonian or der simonian or fixed effect or 
((hand adj2 search*) or (manual* adj2 search*))).tw,hw. Or (retrac-
tion of publication or retracted publication).pt.)
19. Or/13–18
20. Arthroplasty, replacement, knee/
21. Knee prosthesis/
22. ((arthoplast$ adj3 knee$).mp. [mp=title, abstract, original title, 
name of substance word, subject heading word, floating sub- 
heading word, keyword heading word, organism supplementary 
concept) word, protocol supplementary concept) word, rare dis-
ease supplementary concept) word, unique identifier, synonyms]
23. (knee$ adj3 replac$).mp. [mp=title, abstract, original title, name of 
substance word, subject heading word, floating sub- heading word, 
keyword heading word, organism supplementary concept) word, 
protocol supplementary concept) word, rare disease supplementa-
ry concept) word, unique identifier, synonyms]
24. (knee$ adj3 implant$).mp. [mp=title, abstract, original title, name 
of substance word, subject heading word, floating sub- heading 
word, keyword heading word, organism supplementary concept) 
word, protocol supplementary concept) word, rare disease supple-
mentary concept) word, unique identifier, synonyms]
25. (knee$ adj3 prosthe$).mp. [mp=title, abstract, original title, name 
of substance word, subject heading word, floating sub- heading 
word, keyword heading word, organism supplementary concept) 
Continued
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computer navigation and robot assistance; rehabilitation 
regime; study setting to include number of surgeons and 
centres; sponsorship; follow- up intervals; outcome data; 
and information to assess risk of bias. For the categorical 
outcome of revision, we will collect the number of events 
recorded up to a particular follow- up or mean follow- up 
time. For continuous outcomes, we will extract means and 
SD or, if unavailable, make estimates based on medians, 
IQRs and ranges.33 We will contact authors of eligible 
studies by email to maximise available detail concerning 
risk of bias, effect estimates and measures of variability for 
the outcomes of interest.
Depending on the number of studies identified, study 
characteristics will be fully extracted or checked against 
source material by a second reviewer. Outcome data will 
be extracted independently by two reviewers.
Risk of bias assessment
Risk of bias of eligible RCTs will be assessed with the 
revised Cochrane tool (RoB 2).42 Protocols will be sought 
to identify evidence of selective outcome reporting. 
Assessments will be made for all RCTs by two reviewers 
working independently with disagreements resolved with 
other members of the review team. Risk of bias for indi-
vidual studies will be assessed as low, some concerns or 
high risk of bias. In surgical trials, key concerns relate to 
deviations from intended interventions (eg, large propor-
tion of patients not receiving randomised allocation) and 
bias due to missing outcome data (eg, high or unequal 
loss to follow- up). Aspects of risk of bias will be consid-
ered in both meta- analysis and narrative synthesis. Data 
analysis in all meta- analyses will exclude studies assessed 
at high risk of bias.
Data analysis
Pairwise meta-analysis
Data synthesis for the different knee replacement 
constructs defined by constraint, mobility, fixation and 
material will start with a tabulation of study details and 
narrative synthesis. The unit of analysis will be the knee.
Data will be analysed in three different time periods with 
the cut- offs of the period time- points varied in sensitivity 
analysis. Initially, the periods at risk will be: ‘early stage 
failure’ when the construct fails within the first 3 years 
following knee replacement; ‘medium stage failure’ when 
the construct survives the early period but fails within 10 
years from the primary surgery; and ‘late- stage failure’ 
when the construct first fails 10 or more years after the 
primary surgery.
Data analyses will start with pairwise meta- analyses for 
each comparison of knee replacement constructs. The 
effect measure for revision will be the hazard rate ratio. 
Patient- reported and surgeon- assessed outcomes are 
likely to be continuous outcome scores, which will be 
analysed using difference in mean or standardised differ-
ence in mean scores.
If the pairwise meta- analyses include 10 or more RCTs, 
we will produce funnel plots and check for asymmetry, 
which may reflect publication bias.43 If asymmetry is 
noted, we will perform sensitivity analyses with exclusion 
of small studies or conduct meta- regression.33
Network meta-analysis
We will construct a network of studies comparing different 
knee replacement constructs and use network meta- 
analysis to estimate treatment effects informed by both 
direct comparisons within trials and indirect comparisons 
across trials. HRs over the three separate time periods 
(early- stage, medium- stage and late- stage failure) will be 
assumed piecewise constant but the HR of the latter two 
periods will be normally distributed around that of the 
prior period.44 These methods will broadly follow those 
we have used previously.45 46 We do not aim to extrapolate 
outside of the follow- up time of RCTs as this would rely 
on assumptions about the parametric form; as explained 
further, we will use registry data for long- term rates, in 
line with recommendations of the National Institute for 
Health and Care Excellence (NICE) Decision Support 
Unit.47
Network plots will be generated for each outcome to 
illustrate which interventions are compared directly and 
indirectly and the strength of the direct and indirect 
evidence including the number of studies and patients 
available for each direct comparison. Network meta- 
analysis will be implemented in a Bayesian framework 
using OpenBUGS software (V.3.2.3).48 We will adapt 
code developed for our hip replacement surgery network 
meta- analysis,46 which itself was adapted from published 
code.44 In our main analysis, each construct will be consid-
ered a separate intervention forming a distinct node in 
the network of evidence. However, this may result in a 
disconnected network or imprecise effect estimates. We 
will therefore also fit a component network meta- analysis 
model that assumes additivity of the components of each 
construct.49 The additivity assumption will be assessed 
by comparing model fit between the model where each 
construct is distinct and the additive model.
Heterogeneity and subgroup analyses
We aim to fit both fixed and random effects models where 
possible and assess heterogeneity by inspection of the 
between studies SD and comparison of model fit between 
the fixed and random effects models.33 50 However, we 
anticipate that there may be too few replications of indi-
vidual comparisons to fit a random effects model, in 
which case we will implement an informative, evidence- 
based prior distribution for the heterogeneity variance.51 
Model fit is measured by the posterior mean residual devi-
ance (which we expect to be similar to the number of data 
points) and the deviance information criteria52 (which 
penalises fit with a measure of model complexity), with a 
preference for models where these measures are smaller 
(where differences of at least three are considered mean-
ingful). If data allow, we will investigate whether revision 
rates vary according to participant, knee replacement 
construct and trial characteristics (including concerns 
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relating to risk of bias) and surgical methods including 
approach, alignment, computer navigation and robot 
assistance.
If we observe a high level of heterogeneity and cannot 
explain it by patient, study or surgical factors, results from 
the random effects meta- analysis will be reported. If no 
evidence of heterogeneity is found, we will report results 
from the fixed effect model.
We will assess consistency between direct and indirect 
evidence by comparing the fit of the consistency model 
with the fit of an inconsistency model (the unrelated 
mean effects model), which relaxes the consistency 
assumption. Model fit statistics will be compared and the 
contribution to the posterior mean residual deviance 
for each study will be plotted for the consistency model 
against the inconsistency model to identify any particular 
studies contributing to inconsistency.50
Confidence in the evidence
Our confidence in the evidence for each outcome for 
each intervention will be assessed using an extension of 
the Grading of Recommendations Assessment, Develop-
ment, and Evaluation framework developed for network 
meta- analysis and implemented in the CINeMA tool.53 54
Systematic review 2: UKR and TKR
The systematic review and meta- analysis methods used 
comparing UKR with TKR in review 2 will be similar to 
those used in review 1.
Eligibility criteria
Types of studies
We will include RCTs.
Participants
Eligible patients will be as described in review 1 but will 
have been assessed as eligible for both an elective UKR 
and an elective TKR.
Interventions and comparators
The knee replacement constructs will include all compo-
nents used in medial, lateral and patellofemoral UKR and 
in TKR.
To complete the network of studies in review 2, we will 
include studies comparing:
(2a) different types of UKR constructs.
(2b) UKR with TKR constructs.
(2 c) TKR constructs for patients eligible for UKR.
Ascertaining the eligibility of trial participants for 2c 
will be challenging due to paucity of information on 
patient characteristics described at trial level (eg, number 
of symptomatic compartments) and time trends in clin-
ical practice. Clinicians in our team will assess which trials 
may ‘possibly include’ patients potentially eligible for 
UKR in a gradient up to studies that ‘definitely exclude’ 
patients eligible for UKR.
Types of outcome measures
Outcome measures will be as described in review 1.
Search strategy
The search in review 1 includes terms for UKR and thus 
will identify relevant studies. Methods used will mirror 
those of review 1.
Data management
Management of study information, screening and data 
extraction will be as described in review 1. Data extraction 
will additionally include details of whether the UKR is 
for treatment of osteoarthritis in the medial, lateral or 
patellofemoral compartment.
Risk of bias assessment
Assessment of risk of bias will use methods described in 
review 1.
Data analysis
For pairwise and network meta- analyses, we plan main 
analyses restricted to studies (2a) comparing different 
UKR constructs and (2b) comparing UKR and TKR 
constructs. Secondary analyses (2 c) will also include 
comparisons of different TKR constructs in patients 
eligible for UKR.
For review 2a, the reference construct will be the 
most widely used cemented mobile bearing. In reviews 
2b and 2 c, the reference construct within the network 
meta- analysis will be the TKR combination of cemented, 
cruciate- retaining, fixed- bearing implant components 
with metal on polyethylene bearing materials.




In our previous research,55 we have established close links 
between the National Joint Registry for England, Wales, 
Northern Ireland and the Isle of Man (NJR) and the 
Swedish Hip Arthroplasty Register.56 This was a successful 
collaboration, and our analyses benefited from the use of 
similar data collection and management in the two data-
bases and the long follow- up of patients in Sweden. Recog-
nising this, we have established links with the SKAR.57
Data collection in the NJR commenced on 1 April 2003 
and includes 1 193 830 primary knee replacements with 
verifiable patient data up to 31 December 2018.1 In 2020, 
up to 17 years of patient follow- up data are available for 
analysis.
SKAR was established in 1975 and includes patient iden-
tifier numbers that allows tracking of other healthcare 
use.58 More complete data with information required for 
our study has been collected since 1989. Thus, in 2020, 




Patients included in analyses will be aged 18 years or over, 
undergoing primary TKR or UKR for osteoarthritis, with 
valid data on age, sex and construct characteristics.
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Interventions and comparisons
Knee replacement constructs for comparison will be char-
acterised by bearing mobility, constraint, fixation and 
bearing materials. Patella resurfacing is recorded in the 
NJR but is infrequently used in Sweden. We will exclude 
patients receiving patellofemoral and bicompartmental 
knee replacement as they are generally used in a selected 
patient group.
The reference construct will be TKR with cemented, 
cruciate- retaining, fixed- bearing implant components 
with metal on polyethylene bearing materials.
Outcomes
Outcomes for analyses will be time to first, second and 
subsequent revision surgeries and death after primary 
surgery.
Statistical analysis
We will prepare a joint statistical analysis plan for analysis 
of NJR and SKAR data for our research questions. The 
analysis plan will include: definitions of primary surgery, 
knee replacement constructs and techniques, follow- up 
time frames and age groups; statistical methods including 
handling of missing data; and patient characteristics for 
a possible subgroup of TKR patients eligible for UKR. We 
will estimate hazard rates of first and second revision, HRs 
between implants and the effect of covariates (eg, age, 
gender, time since primary surgery and time since first 
revision) on these parameters.
The analyses will be performed using STATA 15.1 soft-
ware. Estimates from the SKAR population will be cali-
brated to the NJR population using a range of calibration 
models implemented in OpenBUGs software as in our 
previous study.55 These calibrations will model some 
difference between SKAR and NJR estimates of hazard 
rates and HRs that is either fixed, random or indepen-
dent over time periods.
Cost-effectiveness analysis
Economic decision models
RCT and registry data will be combined with cost data and 
utility weight estimates to inform a probabilistic lifetime 
decision economic model to determine the relative cost- 
effectiveness from an NHS and social services perspective 
of: (1) TKR constructs and (2) TKR and UKR constructs 
for patients eligible for both. Results will be stratified 
by sex and age group. We will limit knee replacement 
constructs to those available for clinical use in the NHS.
We will calculate expected costs and quality- adjusted 
life years (QALYs), discounted at 3.5% per annum using 
a fully probabilistic analysis, which reflects parameter 
uncertainty in the sampled distributions, and simulating 
some number of iterations. We will first use 10 000 itera-
tions and check if it is sufficient for the mean and SD of 
the cost and QALYs to converge; more simulations will 
be employed if needed. The reference construct for both 
models will be TKR with cemented, cruciate- retaining, 
fixed- bearing implant components with metal on 
polyethylene- bearing materials.
The economic models will be implemented in the open 
source statistical software R.59 The R software has well- 
documented advantages of speed, flexibility and transpar-
ency over other software such as Excel.60 The same models 
will be fitted to both decision populations. Two model 
structures will be explored (full details are included in 
online supplemental material). First is a cohort Markov 
multistate model with health states representing time 
since primary surgery, post first revision, post second or 
higher revision and death.61 States for time since primary 
will correspond to <3 years, ≥3 years but <10 years and 
≥10 years postprimary. The post first revision states will 
correspond to early (<3 years), middle (≥3 years but <10 
years) and late (≥10 years) revision. Probabilities of first 
revision will depend on the time since primary, while 
probabilities of second revision will depend on whether 
the first revision was early, middle or late. Probabilities of 
first revision for each construct and time period and for 
second revision will be calculated using area under the 
curve of estimated hazard rates.62 For first revision, rates 
for the reference construct will come from the NJR/SKAR 
analysis. Rates of first revision for other constructs will be 
calculated by applying time- period specific HRs from the 
network meta- analysis or, if RCT and thus network meta- 
analysis data are not available, NJR/SKAR data.
The second model structure we will use is an individual- 
level continuous time semi- Markov model.63 We aim to 
employ the ‘hesim’ extension to R to implement this 
model.64 States will correspond to no revision, post first 
revision, post second revision and death. Transition rates 
of first revision will depend on time since primary surgery 
and patient characteristics (eg, age and gender). Rates of 
second revision will depend on time from primary to first 
revision and time since first revision. Model parameters 
will be estimated using the same data as for the cohort 
Markov model but without a conversion to probabilities. 
NJR/SKAR will provide rates of first revision for our refer-
ence construct. These will be adjusted to other constructs 
using HRs from the network meta- analysis or, if RCT and 
thus network meta- analysis data are not available for the 
construct or time period, NJR/SKAR estimates of HRs. 
NJR/SKAR will provide rates of second revision, which 
will be assumed common across constructs. This is a 
refinement of the cohort Markov multistate model and 
captures the main deviations from a Markov model in 
the disease area. While results are expected to be similar, 
our base case will be the individual- level continuous time 
semi- Markov model as it places fewer restrictions on 
timings of events.
We will conduct a literature search to identify the best 
data source to derive utility weight estimates stratified by 
age and sex for use in the models. A potential source is 
the UK Patient Reported Outcome Measures (PROMs) 
dataset for patients with knee replacement.65 The PROMs 
dataset includes EuroQol Questionnaire (EQ- 5D- 3L) data 
at 6 months postsurgery for patients over 40 years old.
 on F









pen: first published as 10.1136/bm




9Marques EMR, et al. BMJ Open 2021;11:e040205. doi:10.1136/bmjopen-2020-040205
Open access
Construct prices in GB pounds will be estimated from a 
national database of NHS trusts providing implant procure-
ment prices to the NJR: the NJR INFORM Implant price- 
benchmarking database.66 Primary and revision surgeries, 
and follow- up healthcare costs will be obtained from national 
tariffs.67 We will search the literature for published estimates 
of primary and secondary care follow- up costs from cost- 
effectiveness analyses in RCTs of knee replacement. The 
validity of these costs in the context of our implant construct 
comparisons will be assessed by clinicians in our team.
Cost- effectiveness will be estimated using the mean incre-
mental net monetary benefit statistic (INMB) for each 
knee replacement construct compared with the reference 
construct, a willingness- to- pay threshold of £20 000 per 
QALY.68 The construct with the highest INMB is the most cost- 
effective for each patient subgroup. With cost- effectiveness 
acceptability curves, we will show how the probability of knee 
replacement constructs being most cost- effective varies as 
willingness- to- pay thresholds change.
In sensitivity analyses we will assess the robustness of the 
results to changes in key parameters and assumptions. These 
will involve variation of: time periods over which event hazards 
are assumed constant; estimations of transition probabilities 
(network meta- analysis only, registries only and combination 
of both); model structure to include different health states; 
costs of constructs; time in theatre to perform different 
surgeries; revision TKR costs; and other follow- up costs.
ETHICS AND DISSEMINATION
The systematic reviews will not require ethical approval as we 
are undertaking secondary analyses of published data. For the 
analyses of joint registry data, we will design a common anal-
ysis plan and provide representatives of the NJR and SKAR 
with information required for submission to their respective 
ethics committees. The project has been assessed with the 
NHS REC committee and does not require its ethical review.
We expect the results from our study to provide direct 
patient benefit through better information available for clin-
ical surgical teams performing TKRs, which will influence the 
commissioning of knee replacement constructs used at NHS 
trusts in the UK. We will publish our effectiveness and cost- 
effectiveness findings in two separate peer- reviewed journal 
articles in high- impact open- access journals. The findings of 
our studies will also be disseminated to the NHS, NJR, clini-
cians, societies, charities, patients and the general public via 
presentations, reports and websites.
DISCUSSION
Surgeons and patients are faced with many construct and 
technique options for use in knee replacement. Patients in 
our PPI group told us that they were not informed about 
surgical choices when discussing surgery with their consul-
tant. In a stakeholders meeting, knee surgeons advised us 
that they chose knee replacement constructs based on their 
preferences, surgical skills, availability of implants from 
manufacturers and available research evidence. There is a 
need for a comprehensive synthesis of evidence to inform 
this choice.
Given the large number of knee replacements performed 
annually and stringent NHS budgets, it is important to deter-
mine which knee replacement constructs provide the best 
outcomes for patients at lowest cost to the NHS. Ideally, all 
constructs would be compared in an RCT with long- term 
follow- up and enough statistical power to estimate differ-
ences in revision rates between constructs. However, it would 
be difficult to compare large numbers of constructs in an 
RCT and fund long- term follow- up.
We suggest that a more practical and efficient approach 
is to use all available evidence in published head- to- head 
RCTs to obtain treatment effect estimates for knee replace-
ment constructs. We will complement these with analyses of 
large longitudinal national registries of surgical and patient 
data with long- term follow- up. Both estimates will be used to 
produce economic decision models that will rank and esti-
mate the cost- effectiveness of knee replacement constructs.
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